Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery

Status Withdrawn

Clinical Trial Summary

Blood transfusion is nearly always needed during open heart surgery in children less than 15 kg (35 pounds). The purpose of the red blood cells in the blood is to deliver oxygen to the organs and tissues of the body. Stored blood undergoes some changes that may make it less effective in achieving this goal. The purpose of this study is to see if restoring important energy molecules (ATP and 2,3,DPG) in stored red blood cells before they are transfused, with a rejuvenating solution (Rejuvesol), offers any advantages to children over standard blood transfusion. This is a Food and Drug Administration (FDA) approved process that is described by the American Association of Blood Banks for prolonging blood storage but not used for everyday transfusions. The investigators want to use this process to improve blood transfused to children undergoing heart surgery.

Although Rejuvesol has been previously approved by the FDA, it is not routinely used to prepare standard blood transfusions to children undergoing surgery. Use of Rejuvesol in this study is considered investigational. This is a pilot study and data will be collected for future protocol development.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02485366
Study type	Interventional
Source	Duke University
Contact
Status	Withdrawn
Phase	Phase 4
Start date	June 2020
Completion date	June 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05330338` - Genetics of Ventriculo-arterial Discordance	N/A
Withdrawn	`NCT03405636` - Xeltis Pulmonary Valved Conduit Safety and Performance Study	N/A
Completed	`NCT02443662` - Colloid Osmotic Pressure in Patients With Fontan Circulation
Terminated	`NCT02519335` - Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation	Phase 1
Completed	`NCT01835392` - Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery	N/A
Completed	`NCT00371891` - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)	Phase 4
Completed	`NCT03035552` - CTICU Pacifier Activated Music Player and Mother's Voice	N/A
Recruiting	`NCT04581668` - Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease	N/A
Enrolling by invitation	`NCT04866537` - Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
Completed	`NCT03049540` - Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function	Phase 3
Completed	`NCT02377674` - Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection	N/A
Completed	`NCT01679275` - Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
Terminated	`NCT00543309` - Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery	Phase 2
Completed	`NCT03957512` - Livet Skal Leves (A Life to Live)
Recruiting	`NCT06005428` - Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)	Phase 2
Recruiting	`NCT02691689` - Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions	N/A
Completed	`NCT02306057` - Fluid Balance in Children Undergoing Fontan Surgery	N/A
Recruiting	`NCT02157597` - NIRS Guidance Trail in Children's Heart Surgery	N/A
Completed	`NCT01570933` - Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.	Phase 4
Completed	`NCT00396877` - Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation	Phase 3